frederine

structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Cardiotoxicity 05/01/2001 - "Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity." 05/01/2001 - "Therefore, Frederine merits further investigation as a possible protector against doxorubicin-induced cardiotoxicity in cancer patients." 05/01/2001 - "Complete protection against doxorubicin-induced cardiotoxicity was found, indicating that Frederine is at least 5 times more potent than monoHER. "
2.	Neoplasms (Cancer) 05/01/2001 - "Therefore, Frederine merits further investigation as a possible protector against doxorubicin-induced cardiotoxicity in cancer patients."